| Literature DB >> 35597915 |
Lili Huang1, Lele Li1, Min Wang1, Dongmei Zhang2, Yu Song3.
Abstract
BACKGROUND: Diabetic retinopathy (DR) is one of the most common microvascular complications of diabetes. DR involves a state of systemic inflammation, and chronic inflammation can promote microvascular and macrovascular diseases in diabetic patients and accelerate disease progression. Ultrawide-field FFA (UWFA) systems are increasingly being used to examine a wider retina. The aim of this study was to explore the correlation between the different manifestations of retinopathy under UWFA and the systemic indicators of white blood cells in patients with diabetic retinopathy.Entities:
Keywords: Diabetes mellitus; Diabetic retinopathy; Fundus fluorescein angiography; Inflammation; Neutrophil-to-lymphocyte ratio
Mesh:
Year: 2022 PMID: 35597915 PMCID: PMC9123654 DOI: 10.1186/s12886-022-02442-7
Source DB: PubMed Journal: BMC Ophthalmol ISSN: 1471-2415 Impact factor: 2.086
Fig. 1Female, 52 years old, visited the hospital for 1 week of binocular vision loss (February 22, 2019), 10 years of diabetes history, insulin control, fasting glucose 14.4 mmol/ L. A Fundus fluorescein angiography (FFA) of the venous phase with Heidelberg Spectralis ultrawide angle lens (102°). Dye leakage was found in microvessels in all quadrants, which was recorded as grade 4. The yellow line of the contrast instrument is the nonperfusion area of the retina, which is significantly larger than 7 DD, and it was recorded as grade 1. The optic disc and the retinal surface of each quadrant showed strong fluorescence, indicating neovascularization, recorded as grade 4. No fibrous proliferative membrane was found, grade 0. B FFA of the venous phase with Heidelberg 55° lens. The peripheral retina was limited. C Fundus photography showing the presence and exudation of the retinal surface
Characteristics of the patients
| Characteristics | |
|---|---|
| Age (years) | 56.7 ± 8.9 |
| Sex (male/female) | 62/53 |
| Course of diabetes (years) | 10 (1, 30) |
| HbA1c (%) | 9.6 (5.9, 15.4) |
| Hypertension, n (%) | 54 (47.0) |
| Course of hypertension (years) | 2.0 (0, 40) |
| Number of eyes, n (%) | 199 |
| NPDR | 118 (59.3) |
| Mild | 15 (12.7) |
| Moderate | 10 (8.5) |
| Severe | 93 (78.8) |
| PDR | 81 (40.7) |
| White blood cell count (× 109/L) | 6.50 (3.30, 10.30) |
| Neutrophil ratio (%) | 60.90 (5.00, 83.00) |
| Lymphocyte ratio (%) | 29.10 (9.30, 48.90) |
| Monocyte ratio (%) | 6.40 (1.40, 11.90) |
| Basophil ratio (%) | 0.40 (0.00, 5.70) |
| Eosinophil ratio (%) | 1.60 (0.10, 8.80) |
| NLR (%) | 2.14 (0.78, 40.41) |
HbA1c Glycated hemoglobin, NPDR Non-proliferative diabetic retinopathy, PDR Proliferative diabetic retinopathy, NLR Neutrophil-to-lymphocyte ratio
Characteristic classification of UWFA in diabetic retinopathy
| Image features | Grade 0 | Grade 1 | Grade 2 | Grade 3 | Grade 4 |
|---|---|---|---|---|---|
| Microvascular leakage | 19 (9.5) | 13 (6.5) | 4 (2.0) | 9 (4.5) | 154 (77.4) |
| Capillary nonperfusion area | 105 (52.8) | 94 (47.2) | – | – | – |
| Neovascularization | 118 (59.3) | 32 (16.1) | 19 (9.5) | 14 (7.0) | 16 (8.0) |
| Fibrous proliferative membrane | 183 (92.0) | 16 (8.0) | – | – | – |
Data are presented as n (%)
Correlation between peripheral blood indexes and wide-angle FFA image features
| White blood cell count (r, P) | Neutrophil ratio (r, P) | Lymphocyte ratio (r, P) | Monocyte ratio (r, P) | Basophil ratio (r, P) | Eosinophil ratio (r, P) | NLR (r, P) | |
|---|---|---|---|---|---|---|---|
| Microvascular leakage | 0.049, 0.488 | 0.150, 0.048 | 0.051, 0.476 | 0.105, 0.039 | 0.002, 0.983 | −0.036, 0.610 | 0.186, 0.027 |
| Capillary nonperfusion area | 0.067, 0.346 | 0.029, 0.686 | 0.023, 0.747 | 0.144, 0.042 | −0.092, 0.196 | 0.123, 0.044 | −0.028, 0.693 |
| Neovascularization | 0.048, 0.500 | 0.068, 0.339 | −0.024, 0.732 | 0.324, 0.018 | −0.079, 0.269 | 0.097, 0.174 | 0.023, 0.742 |
| Fibrous proliferative membrane | 0.005, 0.946 | 0.027, 0.701 | 0.009, 0.900 | 0.418, 0.002 | −0.055, 0.440 | −0.007, 0.923 | − 0.045, 0.529 |
NLR Neutrophil-to-lymphocyte ratio
Comparison between diabetic patients without Dr. group and Dr. group
| Variables | DM(80) | DR(115) | |
|---|---|---|---|
| Age (years) | 52 ± 9.5 | 56.7 ± 8.9 | – |
| Sex (male/female) | 48/32 | 62/53 | – |
| Course of diabetes (years) | 4 (1,11) | 10 (1, 30) | – |
| HbA1c (%) | 8.2 (4.8, 13.4) | 9.6 (5.9, 15.4) | – |
| Hypertension, n (%) | 36 (45.0) | 54 (47.0) | – |
| Course of hypertension (years) | 1.6 (0,30) | 2.0 (0, 40) | – |
| White blood cell count (×109/L) | 5.20 (3.80, 7.30) | 6.50 (3.30, 10.30) | 0.04 |
| Neutrophil ratio (%) | 57.54 (52.10,77.10) | 60.90 (5.00, 83.00) | 0.132 |
| Lymphocyte ratio (%) | 29.04 (10.50,46.50) | 29.10 (9.30, 48.90) | 0.964 |
| Monocyte ratio (%) | 5.26 (1.50, 10.80) | 6.40 (1.40, 11.90) | 0.002 |
| Basophil ratio (%) | 0.46 (0.00, 3.72) | 0.40 (0.00, 5.70) | 0.585 |
| Eosinophil ratio (%) | 1.14 (0.20, 6.60) | 1.60 (0.10, 8.80) | 0.042 |
| NLR (%) | 2.02 (0.80, 32.80) | 2.14 (0.78, 40.41) | 0.504 |
Influencing factors of PDR
| Variable | Univariable analyses | Multivariable analysis | ||||
|---|---|---|---|---|---|---|
| OR | 95%CI | OR | 95%CI | |||
| Age | 0.997 | 0.965–1.029 | 0.833 | |||
| Sex | 1.658 | 0.933–2.919 | 0.085 | 1.662 | 0.914–3.023 | 0.096 |
| Course of diabetes | 1.026 | 0.983–1.071 | 0.240 | |||
| HbA1c | 0.985 | 0.850–1.142 | 0.845 | |||
| Hypertension | 1.197 | 0.679–2.109 | 0.535 | |||
| Course of hypertension | 1.009 | 0.969–1.051 | 0.672 | |||
| White blood cell count | 1.076 | 0.900–1.286 | 0.423 | |||
| Neutrophil ratio | 1.018 | 0.987–1.050 | 0.255 | |||
| Lymphocyte ratio | 0.999 | 0.963–1.036 | 0.941 | |||
| Monocyte ratio | 0.872 | 1.748–2.018 | 0.032 | 0.854 | 0.724–1.008 | 0.062 |
| Eosinophil ratio | 1.169 | 1.081–1.392 | 0.040 | 1.250 | 1.039–1.505 | 0.018 |
| Basophil ratio | 1.281 | 0.634–2.587 | 0.491 | |||
| NLR | 0.971 | 0.874–1.079 | 0.585 | |||
OR Odds ratio, CI Confidence interval, HbA1c Glycated hemoglobin, NLR Neutrophil-to-lymphocyte ratio